NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.8860
-0.0240 (-2.64%)
May 14, 2026, 5:24 PM CET
NFL Biosciences Revenue
In the year 2025, NFL Biosciences had annual revenue of 188.00 EUR with 308.70% growth. NFL Biosciences had revenue of 30.00 in the half year ending December 31, 2025.
Revenue
188.00
Revenue Growth
+308.70%
P/S Ratio
61,339.04
Revenue / Employee
37.60
Employees
5
Market Cap
11.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 188.00 | 142.00 | 308.70% |
| Dec 31, 2024 | 46.00 | -199.97K | -99.98% |
| Dec 31, 2023 | 200.01K | 199.99K | 909,040.91% |
| Dec 31, 2022 | 22.00 | -17.00 | -43.59% |
| Dec 31, 2021 | 39.00 | 36.00 | 1,200.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 20.96M |
| Nicox | 18.95M |
| Poxel | 7.66M |
| Advicenne | 7.28M |
| Aelis Farma | 2.33M |
| Plant Advanced Technologies | 2.22M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 656.93K |